GraftWorx seamlessly integrates a sensor package into the bypass graft or stent and interrogates the device daily via a smartphone app.
GraftWorx has already developed a HIPAA-compliant cloud solution able to communicate with our "smart" cardiovascular implantables and securely store and analyze data generated from the sensors.
GraftWorx' integrated cloud platform allows us to identify patients who are at risk of poor outcomes, such as an amputation or heart attack, and allows lower cost preventative measures to be taken. This lowers overall hospital expenditures and decreases readmission rates.
With the new Medicare reimbursement for remote monitoring of chronic conditions, GraftWorx can help clinicians increase revenue by $50-100 per patient per month for their practice while reducing the number of bad outcomes.
"Both Jim Reich and Ray Farnham will be able to advance the sensor technology of our minimally invasive, cardiovascular implants and continue to develop our remote patient monitoring system." GraftWorx, LLC, a new biotech company developing implantable technology for integrated remote patient monitoring, today announced two new members, Jim Reich, a pioneer of sensor technology, and Ray Farnham, former President of mCube, the provider of the world's smallest MEMS motion sensors.